Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
Kappos, Ludwig, Prof, Bates, David, MD, Hartung, Hans-Peter, MD, Havrdova, Eva, MD, Miller, David, MD, Polman, Chris H, MD, Ravnborg, Mads, MD, Hauser, Stephen L, MD, Rudick, Richard A, MD, Weiner, Howard L, MD, O'Connor, Paul W, MD, King, John, MD, Radue, Ernst Wilhelm, MD, Yousry, Tarek, MD, Major, Eugene O, PhD, Clifford, David B, MD
Published in Lancet neurology (01.05.2007)
Published in Lancet neurology (01.05.2007)
Get full text
Journal Article
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Ravnborg, Mads, MD, Sørensen, Per Soelberg, Prof, Andersson, Magnus, MD, Celius, Elisabeth G, MD, Jongen, Peter J, MD, Elovaara, Irina, MD, Bartholomé, Emmanuel, MD, Constantinescu, Cris S, MD, Beer, Karsten, MD, Garde, Ellen, MD, Sperling, Bjørn, MD
Published in Lancet neurology (01.07.2010)
Published in Lancet neurology (01.07.2010)
Get full text
Journal Article